Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06237777
Status:
RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-01-11
Brief Title:
A Clinical Study Evaluating the Safety Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema DME Patients
Sponsor:
Wang Min
Organization:
Eye ENT Hospital of Fudan University
Study Overview
Official Title:
An Open Dose-escalation Clinical Study Evaluating the Safety Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema DME Patients in China
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a clinical study to evaluate the safety tolerability and initial efficacy of SKG0106 intravitreal injection in diabetic macular edema DME patients
Detailed Description:
This is an open dose-escalation clinical study to evaluate the safety tolerability and initial efficacy of SKG0106 intravitreal injection in diabetic macular edema DME patients in China
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None